Granulocyte-Macrophage Colony-Stimulating Factor and Zidovudine: A Phase I Study of Concurrent Administration in Patients With AIDS and Severe ARC
PHASE1CompletedINTERVENTIONAL
Enrollment
60
Participants
Timeline
Start Date
Not specified
Study Completion Date
May 31, 1990
Conditions
HIV InfectionsCytopenias
Interventions
DRUG
Zidovudine
DRUG
Sargramostim
Trial Locations (1)
14215
SUNY / Erie County Med Ctr at Buffalo, Buffalo
All Listed Sponsors
lead
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
NCT00000711 - Granulocyte-Macrophage Colony-Stimulating Factor and Zidovudine: A Phase I Study of Concurrent Administration in Patients With AIDS and Severe ARC | Biotech Hunter | Biotech Hunter